[{"address1": "42127 Pleasant Forest Court", "city": "Ashburn", "state": "VA", "zip": "20148-7349", "country": "United States", "phone": "703 980 4182", "website": "https://quoinpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Myers Ph.D.", "age": 62, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1053788, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Denise  Carter", "age": 55, "title": "Co-Founder, COO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 858245, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sally  Lawlor", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.57, "open": 8.492, "dayLow": 8.0501, "dayHigh": 9.33, "regularMarketPreviousClose": 8.57, "regularMarketOpen": 8.492, "regularMarketDayLow": 8.0501, "regularMarketDayHigh": 9.33, "payoutRatio": 0.0, "beta": 1.955, "trailingPE": 0.009398634, "forwardPE": -7.446281, "volume": 44243, "regularMarketVolume": 44243, "averageVolume": 311456, "averageVolume10days": 38150, "averageDailyVolume10Day": 38150, "bid": 9.39, "ask": 9.07, "bidSize": 1, "askSize": 1, "marketCap": 5435904, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 48.3, "allTimeHigh": 1417500.0, "allTimeLow": 5.01, "fiftyDayAverage": 9.8368, "twoHundredDayAverage": 8.962285, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 180311872, "profitMargins": 0.0, "floatShares": 15725733, "sharesOutstanding": 603319, "sharesShort": 80105, "sharesShortPriorMonth": 4304, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.1328, "heldPercentInsiders": 0.094840005, "heldPercentInstitutions": 0.055419996, "shortRatio": 0.1, "shortPercentOfFloat": 0.1426, "impliedSharesOutstanding": 20585800, "bookValue": 36.003, "priceToBook": 0.25025696, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -12169276, "trailingEps": 958.65, "forwardEps": -1.21, "lastSplitFactor": "1:35", "lastSplitDate": 1744156800, "enterpriseToEbitda": -14.329, "52WeekChange": -0.59776783, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 9.01, "targetHighPrice": 70.0, "targetLowPrice": 25.0, "targetMeanPrice": 40.66667, "targetMedianPrice": 27.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 7790322, "totalCashPerShare": 0.378, "ebitda": -12583419, "totalDebt": 2623733, "quickRatio": 1.796, "currentRatio": 1.955, "debtToEquity": 102.837, "returnOnAssets": -0.6903, "returnOnEquity": -2.42665, "freeCashflow": -6159128, "operatingCashflow": -10696324, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QNRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "longName": "Quoin Pharmaceuticals, Ltd.", "priceEpsCurrentYear": -0.77672416, "fiftyDayAverageChange": -0.8267994, "fiftyDayAverageChangePercent": -0.08405167, "twoHundredDayAverageChange": 0.047715187, "twoHundredDayAverageChangePercent": 0.005323998, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Cellect Biotechnology Ltd.", "nameChangeDate": "2025-11-07", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1762559626, "regularMarketTime": 1762549200, "exchange": "NCM", "messageBoardId": "finmb_593010770", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1470058200000, "postMarketChangePercent": 3.6625962, "postMarketPrice": 9.34, "postMarketChange": 0.32999992, "regularMarketChange": 0.440001, "regularMarketDayRange": "8.0501 - 9.33", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 311456, "fiftyTwoWeekLowChange": 4.0, "fiftyTwoWeekLowChangePercent": 0.79840314, "fiftyTwoWeekRange": "5.01 - 48.3", "fiftyTwoWeekHighChange": -39.29, "fiftyTwoWeekHighChangePercent": -0.8134576, "fiftyTwoWeekChangePercent": -59.776783, "dividendDate": 1571788800, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "earningsCallTimestampStart": 1710419400, "earningsCallTimestampEnd": 1710419400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 958.65, "epsForward": -1.21, "epsCurrentYear": -11.6, "regularMarketChangePercent": 5.1342, "regularMarketPrice": 9.01, "shortName": "Quoin Pharmaceuticals, Ltd.", "displayName": "Quoin Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]